1BSL01AE — Biotika as Balance Sheet
0.000.00%
- €11.90m
- €10.14m
- €13.05m
Annual balance sheet for Biotika as, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2.8 | 2.6 | 3.57 | 1.53 | 7.15 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.26 | 0.89 | 1.51 | 1.34 | 4.79 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 9.93 | 9 | 11.1 | 9.58 | 17 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 14.2 | 13.7 | 13.1 | 12.3 | 10.9 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 30.5 | 28.3 | 30.4 | 27.7 | 33.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.8 | 2.05 | 3.48 | 3.66 | 8.18 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.72 | 2.9 | 4.14 | 4.09 | 11.1 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 26.8 | 25.4 | 26.3 | 23.6 | 22.2 |
| Total Liabilities & Shareholders' Equity | 30.5 | 28.3 | 30.4 | 27.7 | 33.3 |
| Total Common Shares Outstanding |